JS

Jörg Schmitt

VA Vifor (International) Ag: 6 patents #10 of 64Top 20%
Merck: 2 patents #3,919 of 9,382Top 45%
BI Biosynthema: 1 patents #3 of 14Top 25%
📍 Gaienhofen, DE: #2 of 9 inventorsTop 25%
Overall (All Time): #567,795 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
9943498 Fe(III) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias Thomas Bark, Wilm Buhr, Susanna Burckhardt, Michael Burgert, Camillo Canclini +9 more 2018-04-17
9452152 Fe(III) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias Thomas Bark, Wilm Buhr, Susanna Burckhardt, Michael Burgert, Camillo Canclini +9 more 2016-09-27
9439910 Fe(III)-pyrazine complex compounds for treatment and prophylaxis of iron-deficiency phenomena and iron-deficiency anaemia Thomas Bark, Wilm Buhr, Susanna Burckhardt, Michael Burgert, Camillo Canclini +9 more 2016-09-13
9422247 Fe(III) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias Thomas Bark, Wilm Buhr, Susanna Burckhardt, Michael Burgert, Camillo Canclini +9 more 2016-08-23
9394324 Fe(III) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias Thomas Bark, Wilm Buhr, Susanna Burckhardt, Michael Burgert, Camillo Canclini +9 more 2016-07-19
9248134 Fe(III) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias Thomas Bark, Wilm Buhr, Susanna Burckhardt, Michael Burgert, Camillo Canclini +9 more 2016-02-02
7122622 Peptide compounds having improved binding affinity to somatostatin receptors Helmut Macke, Jean Claude Reubi, Mihaela Ginj 2006-10-17
6534478 Cyclic azapeptides with angiogenic effect Alfred Jonczyk, Simon Goodman, Horst Kessler, Jochen Wermuth 2003-03-18
6326403 Diacylhydrazine derivatives as integrin inhibitors Gunter Holzemann, Simon Goodman, Horst Kessler, Christoph Gibson 2001-12-04